301211 Hubei Biocause Heilen Pharmaceutical
- 20.55
- -0.22-1.06%
Hubei Biocause Heilen Pharmaceutical News
Hubei Biocause Heilen Pharmaceutical: 2023 Annual Profit Distribution Implementation Notice
Hendy Pharmaceuticals: Announcement of 2023 Profit Distribution Plan
Hendy Pharmaceutical: 2023-052 indicative announcement on the listing and circulation of some restricted shares in the initial public offering
Hendy Pharmaceutical: 2022 Annual Dividend Distribution and Share Capital Transfer Implementation Notice
Hendy Pharmaceutical: Announcement on 2022 Profit Distribution and Capital Transfer Plan from Capital Provident Fund
Hendy Pharmaceutical: An indicative announcement on the listing and circulation of the initial public placement of restricted shares
Hendy Pharmaceutical: Announcement on 2021 Profit Distribution Plan
Hendy Pharmaceutical: An indicative announcement of the initial public offering of shares and listing on the GEM
Hendy Pharmaceutical: IPO announcement for initial public offering of shares and listing on GEM
Hendy Pharmaceutical: Legal opinion from Guohao Law Firm (Shanghai) on the company's initial public offering of shares and listing on the GEM
Hendy Pharmaceutical: A listing sponsorship letter from Guotai Junan Securities Co., Ltd. regarding the company's initial public offering of shares and listing on the GEM
Hendy Pharmaceutical: Prospectus for initial public offering of shares and listing on GEM
Hendy Pharmaceutical: Announcement of the results of the initial public offering of shares and listing on the GEM
Hendy Pharmaceutical: Initial public offering of shares and listing on GEM and offline distribution announcement of preliminary placement results
Hendy Pharmaceutical: Announcement of the results of the initial public offering of shares and listing on the GEM
Hendy Pharmaceutical: Announcement on online subscription status and winning rate of initial public offering of shares and listing on GEM
Hendy Pharmaceutical: Special Announcement on the Risk of Initial Public Offering of Shares and Listing on the GEM
Hendy Pharmaceutical: Announcement on initial public offering of shares and listing on GEM
Hendy Pharmaceutical: Guotai Junan Securities Co., Ltd.'s special inspection report for strategic investors on the company's initial public offering of shares and listing on the GEM
Hendy Pharmaceutical: Special legal opinion of Shanghai Jinmao Kaide Law Firm on matters relating to strategic investors during the company's initial public offering of shares and listing on the GEM
No Data
